Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 15, 2018
Time Intervals Between Prior Cervical Conization and Posterior Hysterectomy Influence Postoperative Infection in Patients with Cervical Intraepithelial Neoplasia or CancerXinming Yin, Li Zhu, Weiwei Tan, et al.Cancer Chemotherapy and Pharmacology|May 26, 2019
Clinical implications of an analysis of pharmacokinetics of crizotinib coadministered with dexamethasone in patients with non-small cell lung cancerSwan Lin, Dana J Nickens, Maulik Patel, et al.Oncotargets and Therapy|August 2, 2017
Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathwaysWeiwei Tan, Meihong Pan, Hui Liu, et al.Clinical and Translational Science|November 2, 2019
Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug DevelopmentMariam A Ahmed, Chirag Patel, Nicole Drezner, et al.Journal of Cancer|October 2, 2023
SEMA4A promotes prostate cancer invasion: involvement of tumor microenvironmentXiao Liu, Weiwei Tan, Weiqi Wang, et al.Clinical Drug Investigation|February 23, 2022
The Effect of Hepatic Impairment on the Pharmacokinetics of DacomitinibJoseph Piscitelli, Joseph Chen, Robert R LaBadie, et al.The Prostate|April 17, 2015
Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylationWeiwei Tan, Lin Wang, Quanping Ma, et al.Clinical Pharmacology in Drug Development|November 26, 2021
Evaluation of Proton Pump Inhibitor Esomeprazole on Crizotinib Pharmacokinetics in Healthy ParticipantsHuiping Xu, Melissa O'Gorman, Kyle Matschke, et al.Applied Bionics and Biomechanics|January 6, 2023
NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell CarcinomaYongshuai Lin, Facai Zhang, Yinling Jin, et al.Journal of Clinical Pharmacology|July 4, 2014
Evaluation of crizotinib absolute bioavailability, the bioequivalence of three oral formulations, and the effect of food on crizotinib pharmacokinetics in healthy subjectsHuiping Xu, Melissa O'Gorman, Tanya Boutros, et al.Pageof 8